Crossmark

Hesperidin-loaded Nanostructured Lipid Carriers for Mammary Cancer: Optimized Delivery and Pharmacokinetic Enhancement via Quality-by-Design Development

Crossref DOI link: https://doi.org/10.1007/s12247-026-10667-y

Published Online: 2026-05-14

Published Print: 2026-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Raysing, Swati D.

Chaudhari, Nidhi R.

Jain, Pankaj J.

Bagul, Mayur S.
License Information

Text and Data Mining valid from 2026-05-14

Version of Record valid from 2026-05-14
More Information

Article History

Received: 16 December 2025

Accepted: 2 April 2026

First Online: 14 May 2026

Declarations

:

: The animal studies were performed after receiving approval of the Institutional Animal Ethical Committee (IAEC) in R. C. Patel Institute of Pharmaceutical Education & Research (Reference number: IAEC/RCPIPER/2024-25/52).

: The authors declare no competing interests.

Document is current

Any future updates will be listed below